Advertisement

New meds help drugmakers weather strong dollar, other issues

By Associated Press  |  April 28, 2015

Revenue from important new medicines for various cancers, hepatitis C and more helped top U.S. drugmakers weather unfavorable currency exchange rates and other challenges. Pfizer, Merck & Co. and Bristol-Myers Squibb Co., which reported first-quarter results Tuesday, all derive at least half their...

FDA backs biosimilar; drugs could save billions

By Steven Ross Johnson  |  March 07, 2015

Federal regulators have approved the first biosimilar drug to be sold in the U.S., a move that could lower treatment costs as biosimilars compete with what historically had been more expensive medications.

Merck committed to Cubist after patent losses

By Associated Press  |  December 09, 2014

Merck remains committed to its $8.4 billion acquisition of Cubist Pharmaceuticals even though a federal court invalidated most of the patents protecting the company's top-selling antibiotic just hours after that deal was announced Monday.

FDA cites Hospira for drug manufacturing violations

By Bob Herman  |  October 01, 2014

Drugmaker Hospira said Wednesday that it received a warning letter from the Food and Drug Administration regarding poor manufacturing quality at one of its facilities in Australia.

Premier's TheraDoc deal boosts its clinical surveillance business

Premier's TheraDoc deal boosts its clinical surveillance business

By Bob Herman  |  August 05, 2014

Healthcare supply, analytics and consulting company Premier agreed Tuesday to acquire TheraDoc, a clinical surveillance software company, for $117 million, augmenting Premier's already sizable footprint in the clinical-safety solutions market.

AHA wants FDA to address IV fluids shortage

AHA wants FDA to address IV fluids shortage

By Virgil Dickson  |  March 21, 2014

The American Hospital Association is pushing the Food and Drug Administration to be more aggressive in getting manufacturers of saline and other IV fluids to increase production to alleviate shortages.

FDA efforts take aim at drug shortages

FDA efforts take aim at drug shortages

By Virgil Dickson  |  October 31, 2013

The FDA is releasing a strategic plan to address the underlying causes of drug shortages, and will launch a new mobile app to alert relevant stakeholders when shortages occur.

ActiveCare names Olson CTO

ActiveCare names Olson CTO

By Rachel Landen  |  June 20, 2013

ActiveCare, which provides remote health monitoring for diabetes and chronic disease management, has named Jonathan Olson its chief technology officer.

Hungry for a solution

Hungry for a solution

By Jaimy Lee  |  June 08, 2013

Tim Weaver, an 18-year-old college student who lives in Naperville, Ill., is one of the estimated 30,000 people in the U.S. who rely on intravenous nutrition products to keep them alive.

Hospira wins skirmish with SEC

By Kristen Schorsch, Crain's Chicago Business  |  January 15, 2013

Hospira successfully fought off a government request for more details about its prolonged efforts to fix safety problems, a win that highlights the scrutiny of CEO F. Michael Ball's efforts to boost production at the giant medical products maker.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.